World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
105
Citations
57147
World Ranking
576
National Ranking
344

Dario A. A. Vignali publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dario A. A. Vignali sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 297 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dario A. A. Vignali D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dario A. A. Vignali sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 105 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dario A. A. Vignali is affiliated with the University of Pittsburgh in the United States and conducts research primarily in the fields of Medicine, Immunology, and Microbiology. Their scholarly work spans multiple subfields including Immunology, Oncology, Molecular Biology, Neurology, and Pulmonary and Respiratory Medicine.

Their research focuses on key topics such as Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, T-cell and B-cell Immunology, CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune cells in cancer, and Gut microbiota and health.

Among recent publications, Vignali is associated with the following papers:

  • Metabolic support of tumour-infiltrating regulatory T cells by lactic acid (2021, Nature)
  • Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer (2020, Immunity)
  • Interferon-γ: teammate or opponent in the tumour microenvironment? (2021, Nature Reviews Immunology)
  • Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment (2023, Cell)
  • B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma (2021, Nature Communications)

Vignali collaborates frequently with several co-authors, including:

  • Creg J. Workman
  • Tullia C. Bruno
  • Anthony R. Cillo
  • Robert L. Ferris
  • Sayali Onkar

Their work has been published extensively in venues such as:

  • The Journal of Immunology
  • Regular and Young Investigator Award Abstracts
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Immunology
  • Clinical Cancer Research

Best Publications

  • How regulatory T cells work.

    Dario A. A. Vignali;Lauren W. Collison;Creg J. Workman

  • The inhibitory cytokine IL-35 contributes to regulatory T-cell function

    Lauren W. Collison;Creg J. Workman;Timothy T. Kuo;Kelli Boyd

  • Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

    Shawn D Blackburn;Haina Shin;W Nicholas Haining;W Nicholas Haining;Tao Zou

  • Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape

    Seng Ryong Woo;Meghan E Turnis;Monica V Goldberg;Jaishree Bankoti

  • Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.

    Kazuya Shimoda;Jan van Deursent;Mark Y. Sangster;Sally R. Sarawar

  • Role of LAG-3 in regulatory T cells.

    Ching Tai Huang;Creg J. Workman;Dallas Flies;Xiaoyu Pan

  • Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells

    W. E. Thierfelder;J. M. Van Deursen;K. Yamamoto;R. A. Tripp

  • Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

    Andrea L Szymczak;Andrea L Szymczak;Creg J Workman;Yao Wang;Kate M Vignali

  • IL-12 family cytokines: immunological playmakers

    Dario A A Vignali;Vijay K Kuchroo

  • Multiplexed particle-based flow cytometric assays.

    Dario A.A. Vignali

  • Metabolic support of tumour-infiltrating regulatory T cells by lactic acid.

    McLane L.J. Watson;Paolo D.A. Vignali;Steven J. Mullett;Abigail E. Overacre-Delgoffe;Abigail E. Overacre-Delgoffe

  • Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

    R. M. Chicz;R. G. Urban;J. C. Gorga;D. A. A. Vignali

  • IL-35-mediated induction of a potent regulatory T cell population

    Lauren W Collison;Vandana Chaturvedi;Abigail L Henderson;Abigail L Henderson;Paul R Giacomin

  • LAG3 (CD223) as a cancer immunotherapy target.

    Lawrence P. Andrews;Ariel E. Marciscano;Charles G. Drake;Dario A. A. Vignali

  • Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size

    Roman M. Chicz;Robert G. Urban;William S. Lane;Joan C. Gorga;Joan C. Gorga

  • Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3

    Jun Wang;Miguel F. Sanmamed;Ila Datar;Tina Tianjiao Su

  • Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3

    Xiaobo Mao;Michael Tianhao Ou;Senthilkumar S. Karuppagounder;Tae In Kam

  • Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II

    Bitao Liang;Craig Workman;Janine Lee;Claude Chew

  • Regulatory T cells: recommendations to simplify the nomenclature

    Abul K Abbas;Christophe Benoist;Jeffrey A Bluestone;Daniel J Campbell

  • Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling

    Sivakumar Vallabhapurapu;Atsushi Matsuzawa;Wei Zhou Zhang;Ping Hui Tseng

  • Stability and function of regulatory T cells is maintained by a neuropilin-1–semaphorin-4a axis

    Greg M. Delgoffe;Seng-Ryong Woo;Meghan E. Turnis;David M. Gravano

Frequent Co-Authors

Creg J. Workman
Creg J. Workman University of Pittsburgh
Tullia C. Bruno
Tullia C. Bruno University of Pittsburgh
Robert L. Ferris
Robert L. Ferris University of Pittsburgh
Jonathan D. Powell
Jonathan D. Powell Johns Hopkins University School of Medicine
Charles G. Drake
Charles G. Drake Columbia University
Jack L. Strominger
Jack L. Strominger Harvard University
Arlene H. Sharpe
Arlene H. Sharpe Harvard University
Bruce R. Blazar
Bruce R. Blazar University of Minnesota
David L. Woodland
David L. Woodland Trudeau Institute
Robert Lafyatis
Robert Lafyatis University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology and interested in healthcare, exploring related online degrees can open diverse career pathways. Programs such as accelerated nurse practitioner options allow students to quickly gain advanced clinical skills, blending scientific knowledge with patient care. These opportunities make transitioning into healthcare roles more accessible for many.

Many individuals start their nursing careers with an online BSN program for non nurses, which provides foundational nursing education for those without prior healthcare backgrounds. From there, advancing to specialized roles is possible through focused bridge programs like the fnp to acute care np bridge program, designed to help nurse practitioners expand their expertise in acute care settings.

Understanding salary expectations can also guide career decisions. For example, data on how much do dnps make highlights regional salary differences that can influence job location choices and financial planning.

Overall, combining immunology knowledge with targeted nursing degrees not only broadens career options but also enhances the ability to contribute to patient outcomes in specialized clinical roles.

Best Scientists Citing Dario A. A. Vignali

Trending Scientists

Recently Published Articles